Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY: PLX )

1.810 +0.030 (+1.69%)
Streaming Delayed Price Updated: 12:15 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Protalix BioTherapeutics, Inc. (DE) Common Stock

< Previous 1 2 3 Next >
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 29 companies hit new 52-week lows. Noteables: The largest company in terms of market cap to set a new 52-week low was China Life Insurance Co... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET Monday, 8 stocks made new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was TAL Education (NYSE:TAL... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 7 companies hit new 52-week lows. Key Facts: The largest company by market cap to set a new 52-week low was TAL Education (NYSE:TAL). The company... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday morning, 11 companies achieved new lows for the year. Intriguing Points: TAL Education (NYSE:TAL) was the biggest company on a market cap basis to set a new 52... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
66 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... 
Via Benzinga
Mid-Afternoon Market Update: Constellation Pharmaceuticals Surges Following Acquisition News; Protalix BioTherapeutics Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.05% to 34,594.18 while the NASDAQ fell 0.16% to 13,715.08. The S&P also rose, gaining 0.02% to 4,202.76. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge
`Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX... 
Via Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-... 
Via Benzinga
Looking Into Protalix BioTherapeutics's Return On Capital Employed
Protalix BioTherapeutics (AMEX:PLX) reported Q1 sales of $11.32 million. Earnings fell to a loss of $3.71 million, resulting in a 230.5% decrease from last quarter. In Q4,... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian... 
Via Benzinga
Earnings Scheduled For May 14, 2021
Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report... 
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
Earnings Preview for Protalix BioTherapeutics
On Friday, May 14, Protalix BioTherapeutics (AMEX:PLX) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
22 Stocks Moving in Monday's Pre-Market Session
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
Via Benzinga
Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged
Toward the end of trading Wednesday, the Dow traded down 0.26% to 33,894.93 while the NASDAQ fell 0.01% to 14,090.09. However, the S&P gained 0.13% to 4,192.05. The U.S. has... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
60 Biggest Movers From Yesterday
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
Via Benzinga
Why Protalix BioTherapeutics Stock Is Plunging Today
Investors did not like the company's latest regulatory update. 
Via The Motley Fool
Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge
Midway through trading Wednesday, the Dow traded down 0.33% to 33,874.02 while the NASDAQ fell 0.07% to 14,079.66. The S&P also rose, gaining 0.15% to 4,193.17. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations
Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P also rose, gaining 0.19% to 4,194.68. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... 
Via Benzinga
Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease
Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici, have received a Complete Response... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.